Publications by authors named "Jenn-Yu Wu"

Claim this Profile
E
Effectiveness of Treatments for Advanced Non-Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations.
Jenn-Yu Wu, Chong-Jen Yu, Jin-Yuan Shih

Clin Lung Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series.
Hung-Chieh Yeh, I-Wen Ting, Ching-Wei Tsai, Jenn-Yu Wu, Chin-Chi Kuo

BMC Nephrol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer.
Jenn-Yu Wu, Jin-Yuan Shih

Onco Targets Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis.
Shang-Gin Wu, Fu-Chang Hu, Yih-Leong Chang, Yung-Chie Lee, Chong-Jen Yu, Jenn-Yu Wu

Eur Respir J· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR.
Kuei-Pin Chung, Shang-Gin Wu, Jenn-Yu Wu, James Chih-Hsin Yang, Chong-Jen Yu

Clin Cancer Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer.
Jenn-Yu Wu, Chong-Jen Yu, Yeun-Chung Chang, Chih-Hsin Yang, Jin-Yuan Shih

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations.
Jenn-Yu Wu, Shang-Gin Wu, Chih-Hsin Yang, Yih-Leong Chang, Yeun-Chung Chang

Lung Cancer· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations.
Jenn-Yu Wu, Jin-Yuan Shih, Kuan-Yu Chen, Chih-Hsin Yang, Chong-Jen Yu

Medicine (Baltimore)· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer.
Jenn-Yu Wu, Chih-Hsin Yang, Ya-Chieh Hsu, Chong-Jen Yu, Shih-Han Chang

Clin Lung Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kommerell diverticulum, right-sided aorta, and left aberrant subclavian artery in a patient with dysphagia.
Jenn-Yu Wu, Hsin-Yi Chen, Chin-Chung Shu, Chong-Jen Yu

J Thorac Cardiovasc Surg· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer.
Jenn-Yu Wu, Chong-Jen Yu, Jin-Yuan Shih, Chih-Hsin Yang, Pan-Chyr Yang

Lung Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer.
Jenn-Yu Wu, Jin-Yuan Shih, Chih-Hsin Yang, Kuan-Yu Chen, Chao-Chi Ho

Int J Cancer· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of non-invasive ventilation and factors predicting extubation outcome in myasthenic crisis.
Jenn-Yu Wu, Ping-Hung Kuo, Pi-Chuan Fan, Huey-Dong Wu, Fuh-Yuan Shih

Neurocrit Care· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection.
Jenn-Yu Wu, Shang-Gin Wu, Hsin-Yun Sun, Ping-Hung Kuo, Pan-Chyr Yang

J Hosp Med· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern.
Shang-Gin Wu, Yih-Leong Chang, Ya-Chieh Hsu, Jenn-Yu Wu, Chih-Hsin Yang

Oncologist· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer.
Jenn-Yu Wu, Chong-Jen Yu, Chih-Hsin Yang, Shang-Gin Wu, Yueh-Hsia Chiu

Am J Respir Crit Care Med· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenal insufficiency in prolonged critical illness.
Jenn-Yu Wu, Szu-Chun Hsu, Shih-Chi Ku, Chao-Chi Ho, Chong-Jen Yu

Crit Care· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response.
Jenn-Yu Wu, Shang-Gin Wu, Chih-Hsin Yang, Chien-Hung Gow, Yih-Leong Chang

Clin Cancer Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leg pains, clubbing of digits and lung mass: what is your call?
Jenn-Yu Wu, Jin-Yuan Shih

CMAJ· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis